Haemonetics Corp (HAE)

Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell

$56.65

Buy

$73.37

arrow-up$0.74 (+1.06%)

Haemonetics Corp is a health care company. It provides products enabling in the processing, handling and analysis of blood and portfolio of integrated devices and information management tools to improve clinical outcomes.
Prices updated at 05 Jun 2025, 21:20 EDT
| Prices minimum 15 mins delay
|
Prices in USD
S&P 500
arrow-down-0.53%
NYSE
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.

Income statement

Year
chevron-l-regular
chevron-r-regular
20182019202020212022202320242025
904m968m988m870m993m1,169m1,309m1,361m
412m418m485m398m506m615m692m749m
56m84m146m57m71m156m173m201m
6.218.6314.766.547.1613.3213.2414.78
46m55m77m79m43m115m118m168m
153m193m214m174m178m249m262m337m
Sales, General and administrative317m273m282m275m340m377m432m437m
Interest expenses5m10m16m17m17m15m13m10m
Provision for income taxes14m19m11m-7m20m26m34m44m
Operating expenses356m334m339m341m434m459m518m548m
Income before taxes60m74m87m73m64m141m152m212m
Net income available to common shareholders46m55m77m79m43m115m118m168m
0.881.572.140.441.882.52.563.33
Net interest income-5m-10m-16m-17m-17m-15m-13m-10m
Advertising and promotion--------
Net investment income, net--------
Realised capital gains (losses), net--------
Total benefits, claims and expenses--------
Earnings per share (diluted)0.861.532.120.431.862.462.543.31
Free cash flow per share1.52270.96762.33051.04862.25923.88260.39581.3817
Book value/share13.753711.584613.143613.668814.451717.596917.494818.9526
Debt equity ratio0.0789750.4828110.6089620.9438570.7464950.9218880.8308311.122307

Balance sheet

Year
chevron-l-regular
chevron-r-regular
20182019202020212022202320242025
Current assets521m576m604m694m756m770m769m935m
Current liabilities385m236m275m253m442m252m300m578m
Total capital812m990m893m1,422m1,309m1,572m1,758m1,742m
Total debt254m350m442m778m781m766m808m1,225m
Total equity752m668m587m732m749m818m960m821m
Total non current liabilities--------
Loans59m322m306m691m559m754m798m921m
Total assets1,237m1,275m1,267m1,820m1,860m1,935m2,196m2,451m
Total liabilities--------
Cash and cash equivalents180m169m137m192m259m284m179m307m
Common stock52m51m50m51m51m50m51m48m

Cash flow

Year
chevron-l-regular
chevron-r-regular
20182019202020212022202320242025
Cash at beginning of period140m180m169m137m192m259m284m179m
Cash dividends paid--------
146m40m109m72m76m163m115m142m
Investments (gains) losses-63m-116m-57m-425m-86m-144m-322m-162m
180m169m137m192m259m284m179m307m
Net income--------
220m159m158m109m172m273m182m182m
-75m-119m-49m-37m-97m-110m-66m-39m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.